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Introduction and Aims:Magnesium (Mg2+) is an essential mineral for cell growth,
neuroplasticity and muscle contraction. Blood Mg2+ levels below 0.7 mmol/L may
cause a heterogeneous clinical phenotype, including muscle cramps, epilepsy and
disturbances in K+ and Ca2+ homeostasis. Over the last decade, the genetic origin of
several familial forms of hypomagnesemia has been delineated. In 2000, mutations in
FXYD2, encoding the γ-subunit of the Na+-K+-ATPase, were identified to cause
isolated dominant hypomagnesemia (IDH) in a large Dutch family suffering from
hypomagnesemia, hypocalciuria and chondrocalcinosis. However, additional patients
were never identified.
Methods: Here, two families with hypomagnesemia and hypocalciuria were screened
for mutations in the FXYD2 gene. Moreover, the patients were clinically and
genetically characterized.
Results:We report a p.Gly41Arg FXYD2 mutation in two families with
hypomagnesemia and hypocalciuria. The patients suffered from muscle cramps,
chondrocalcinosis and epilepsy. The p.Gly41Arg substitution introduces a charged
amino acid residue in the predicted transmembrane region of the γ-subunit of the Na
+-K+-ATPase. As a consequence, the γ-subunit lacks post-translational modifications
and is not routed to the plasma membrane. Interestingly, this is exactly the same
mutation as was described in the original study. Haplotype analysis revealed an
overlapping haplotype in all families, suggesting a founder effect. However, extensive
genealogical analysis did not reveal a common ancestor in 9-12 generations.
Conclusions: The recurrent p.Gly41Arg FXYD2 mutation in two new families with
isolated dominant hypomagnesemia confirms that the FXYD2 mutation causes
hypomagnesemia. Until now, no other FXYD2 mutations have been reported which
could indicate that other FXYD2 mutations will not cause hypomagnesemia or are
embryonically lethal.
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